Hauser RA - Search Results

1

Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets.

Espay AJ, LeWitt PA, Hauser RA, Merola A, Masellis M, Lang AE. Espay AJ, et al. Among authors: hauser ra. Lancet Neurol. 2016 Aug;15(9):954-966. doi: 10.1016/S1474-4422(16)30079-5. Lancet Neurol. 2016. PMID: 27478953 Review.

2

Depression in Parkinson's disease.

Zesiewicz TA, Hauser RA. Zesiewicz TA, et al. Among authors: hauser ra. Curr Psychiatry Rep. 2002 Feb;4(1):69-73. doi: 10.1007/s11920-002-0016-7. Curr Psychiatry Rep. 2002. PMID: 11814399 Review.

3

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.

Whone AL, Watts RL, Stoessl AJ, Davis M, Reske S, Nahmias C, Lang AE, Rascol O, Ribeiro MJ, Remy P, Poewe WH, Hauser RA, Brooks DJ; REAL-PET Study Group. Whone AL, et al. Among authors: hauser ra. Ann Neurol. 2003 Jul;54(1):93-101. doi: 10.1002/ana.10609. Ann Neurol. 2003. PMID: 12838524 Clinical Trial.

4

Factors associated with the development of motor fluctuations and dyskinesias in Parkinson disease.

Hauser RA, McDermott MP, Messing S. Hauser RA, et al. Arch Neurol. 2006 Dec;63(12):1756-60. doi: 10.1001/archneur.63.12.1756. Arch Neurol. 2006. PMID: 17172616 Clinical Trial.

5

Advances in the pharmacologic management of early Parkinson disease.

Hauser RA, Zesiewicz TA. Hauser RA, et al. Neurologist. 2007 May;13(3):126-32. doi: 10.1097/01.nrl.0000256433.15481.eb. Neurologist. 2007. PMID: 17495756 Review.

6

Levodopa-induced dyskinesia in Parkinson's disease: epidemiology, etiology, and treatment.

Zesiewicz TA, Sullivan KL, Hauser RA. Zesiewicz TA, et al. Among authors: hauser ra. Curr Neurol Neurosci Rep. 2007 Jul;7(4):302-10. doi: 10.1007/s11910-007-0046-y. Curr Neurol Neurosci Rep. 2007. PMID: 17618536 Review.

7

Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa.

Hauser RA, Rascol O, Korczyn AD, Jon Stoessl A, Watts RL, Poewe W, De Deyn PP, Lang AE. Hauser RA, et al. Mov Disord. 2007 Dec;22(16):2409-17. doi: 10.1002/mds.21743. Mov Disord. 2007. PMID: 17894339 Clinical Trial.

8

Serum urate as a predictor of clinical and radiographic progression in Parkinson disease.

Schwarzschild MA, Schwid SR, Marek K, Watts A, Lang AE, Oakes D, Shoulson I, Ascherio A; Parkinson Study Group PRECEPT Investigators; Hyson C, Gorbold E, Rudolph A, Kieburtz K, Fahn S, Gauger L, Goetz C, Seibyl J, Forrest M, Ondrasik J. Schwarzschild MA, et al. Arch Neurol. 2008 Jun;65(6):716-23. doi: 10.1001/archneur.2008.65.6.nct70003. Epub 2008 Apr 14. Arch Neurol. 2008. PMID: 18413464 Free PMC article. Clinical Trial.

9

A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics.

Olanow CW, Hauser RA, Jankovic J, Langston W, Lang A, Poewe W, Tolosa E, Stocchi F, Melamed E, Eyal E, Rascol O. Olanow CW, et al. Among authors: hauser ra. Mov Disord. 2008 Nov 15;23(15):2194-201. doi: 10.1002/mds.22218. Mov Disord. 2008. PMID: 18932271 Clinical Trial.

10

Treatment of early Parkinson's disease. Part 1.

Simuni T, Lyons KE, Pahwa R, Hauser RA, Comella C, Elmer L, Weintraub D. Simuni T, et al. Among authors: hauser ra. Eur Neurol. 2009;61(4):193-205. doi: 10.1159/000197103. Epub 2009 Jan 29. Eur Neurol. 2009. PMID: 19176960 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

338 results

Search Page

Filters